首页> 美国卫生研究院文献>PLoS Clinical Trials >Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps
【2h】

Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps

机译:Bcl-2介导的非小细胞肺癌细胞NCI-H460中TRAIL诱导的凋亡反应的控制在caspase后期加工中有效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Dysregulation of the mitochondrial signaling pathway of apoptosis induction represents a major hurdle in tumor therapy. The objective of the presented work was to investigate the role of the intrinsic (mitochondrial) apoptotic pathway in the non-small lung cancer cell line NCI-H460 upon induction of apoptosis using the highly bioactive TRAIL derivative Db-scTRAIL. NCI-H460 cells were TRAIL sensitive but an only about 3 fold overexpression of Bcl-2 was sufficient to induce a highly TRAIL resistant phenotype, confirming that the mitochondrial pathway is crucial for TRAIL-induced apoptosis induction. TRAIL resistance was paralleled by a strong inhibition of caspase-8, -9 and -3 activities and blocked their full processing. Notably, especially the final cleavage steps of the initiator caspase-8 and the executioner caspase-3 were effectively blocked by Bcl-2 overexpression. Caspase-9 knockdown failed to protect NCI-H460 cells from TRAIL-induced cell death, suggesting a minor role of this initiator caspase in this apoptotic pathway. Rather, knockdown of the XIAP antagonist Smac resulted in enhanced caspase-3 degradation after stimulation of cells with TRAIL. Of note, downregulation of XIAP had only limited effects on TRAIL sensitivity of wild-type NCI-H460 cells, but resensitized Bcl-2 overexpressing cells for TRAIL-induced apoptosis. In particular, XIAP knockdown in combination with TRAIL allowed the final cleavage step of caspase-3 to generate the catalytically active p17 fragment, whose production was otherwise blocked in Bcl-2 overexpressing cells. Together, our data strongly suggest that XIAP-mediated inhibition of final caspase-3 processing is the last and major hurdle in TRAIL-induced apoptosis in NCI-H460 cells, which can be overcome by Smac in a Bcl-2 level dependent manner. Quantitative investigation of the XIAP/Smac interplay using a mathematical model approach corroborates our experimental data strengthening the suggested roles of XIAP and Smac as critical determinants for TRAIL sensitivity.
机译:凋亡诱导的线粒体信号传导途径的失调是肿瘤治疗中的主要障碍。提出的工作的目的是研究使用高度生物活性的TRAIL衍生物Db-scTRAIL诱导非小细胞肺癌细胞NCI-H460内在(线粒体)凋亡途径的作用。 NCI-H460细胞对TRAIL敏感,但Bcl-2的仅约3倍的过表达足以诱导高度TRAIL抗性表型,这证明线粒体途径对于TRAIL诱导的凋亡诱导至关重要。 TRAIL耐药性与caspase-8,-9和-3活性的强烈抑制同时发生,并阻止了它们的完全加工。值得注意的是,尤其是启动子caspase-8和the子手caspase-3的最终切割步骤被Bcl-2过表达有效地阻断了。 Caspase-9敲低未能保护NCI-H460细胞免受TRAIL诱导的细胞死亡,表明该启动子caspase在此凋亡途径中的作用很小。相反,在用TRAIL刺激细胞后,XIAP拮抗剂Smac的敲低导致caspase-3降解增强。值得注意的是,XIAP的下调仅对野生型NCI-H460细胞的TRAIL敏感性具有有限的影响,但是使Bcl-2过表达的细胞对TRAIL诱导的凋亡重新敏感。尤其是,XIAP敲低与TRAIL的结合使caspase-3的最终切割步骤产生了催化活性的p17片段,而该片段的产生在Bcl-2过表达的细胞中被阻断。在一起,我们的数据强烈表明,XIAP介导的对最终caspase-3加工的抑制是TRAIL诱导的NCI-H460细胞凋亡的最后一个主要障碍,Smac可以通过Bcl-2水平依赖性的方式克服这一障碍。使用数学模型方法对XIAP / Smac相互作用进行定量研究,证实了我们的实验数据,进一步证明了XIAP和Smac作为TRAIL敏感性的关键决定因素的建议作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号